A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons

NCT00000743 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Alvircept sudotox
DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]